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Abstract
Background: Muscle adaptation which occurs follow-
ing eccentric exercise-induced muscle damage has
been associated with an acute inflammatory
response. The purpose of this study was to investi-
gate serum interleukin-6 (IL-6), osteoprotegerin and
receptor activator of nuclear factor kB ligand (OPG/
RANKL) concentrations following muscle damage.
We measured changes for several days following
muscle damage.
Methods: Ten healthy young males performed an
eccentric exercise protocol using their quadriceps.
Blood samples were withdrawn before and at 6 h,
2 days, 5 days and 16 days post-exercise. Functional
and clinical measurements were performed before,
and on days 1, 2, 5, 8, 12 and 16 post-exercise.
Results: The exercise protocol resulted in muscle
damage, indicated by changes in biochemical mark-
ers. An increase in IL-6 and OPG, and a decrease in
RANKL concentrations were seen at 6 h and on day 2
post-exercise; the OPG:RANKL ratio was increased at
6 h post-exercise (p-0.05).
Conclusions: Changes in IL-6 and OPG/RANKL system
may represent systemic responses in muscle inflam-
mation and repair processes. However, further stud-
ies are needed to elucidate a potential systemic and/
or local role of the OPG/RANKL system in skeletal
muscle repair.
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Introduction
Activity such as muscle overload and muscle stretch,
or combination of both that occurs in eccentric exer-
cise has been shown to result in muscle damage
(1–5). Exercise-induced muscle damage has been
associated with disruption of the normal myofilament
structures in sarcomeres (6), damage to sarcolemma,
loss of fiber integrity and leakage of muscle-specific
enzymes and proteins into the blood (7), acute inflam-
matory response (8–11), delayed-onset muscle sore-
ness and loss of muscle contraction force (12).
Muscle adaptation that occurs following damage
has been explained by the classic damage-inflam-
mation-regeneration process (8, 13, 14). It is thought
that exercise-induced muscle damage is associated
with aseptic inflammation, and the primary purpose
of this inflammation is the repair of damaged tissue
(8, 11). Coordination between inflammation and
regeneration is crucial for successful recovery of dam-
aged muscle (13). Also, much of the acute inflam-
matory response induced by muscle damage is
coordinated by the de novo synthesis of endogenous
cytokines that direct inflammatory-related events (15,
16). Cytokines may be produced by a variety of cells
including endothelial cells, tissue-resident leukocytes
and circulating leukocytes (15, 17). They contribute to
specific aspects of acute inflammation and may be
characterized as either pro- or anti-inflammatory,
based on their predominant action (18).
Osteoprotegerin (OPG) and receptor activator of
nuclear factor kB ligand (RANKL) are specific modu-
lators of the immune system (19, 20). However, no
previous work has been done to examine the poten-
tial role of these endogenous cytokines regarding
exercise-induced muscle damage and adaptation.
Hence, the aim of our study was to illuminate the
changes in interleukin (IL)-6 and the OPG/RANKL sys-
tem in blood. We measured these changes for several
days following eccentric exercise-induced muscle
damage in young men.
Materials and methods
Ethical approval
Written informed consent was obtained by all volunteers
participating in this study, which has been approved by the
Ethics Committee of the National and Kapodistrian Univer-
sity of Athens. All experimental procedures conformed to the
Declaration of Helsinki.
Subjects
Ten healthy men (age 25"1.5 years, height 180.3"1.5 cm,
body mass 76.8"2.4 kg, body mass index 23.6"0.5 kg/m2)
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participated in the study. The volunteers were physically
active, but not accustomed to high-intensity eccentric exer-
cise and had not participated in any type of resistance train-
ing or regular exercise regime for at least 6 months before
the study. These individuals were free of any musculoskel-
etal disorders or other lower extremity pathologies. They
refrained from taking any medications or nutritional supple-
ments throughout the experimental period. The volunteers
were not allowed to perform any vigorous physical activities
or quadriceps muscle stretching during the entire experi-
mental period. They were also instructed to maintain their
normal diet with no alcohol. On the day prior to, and the day
of each blood collection, they were asked to have the same
meals.
Experimental design
The volunteers performed a maximal eccentric exercise pro-
tocol of the knee extensor muscles with each leg. Post-
eccentric exercise, one leg served for the assessment of
muscle function (the functional assessment leg, FL). The con-
tralateral leg was used as a control (the control leg, CL) in
order to assess any potential training effects of repeated
maximal torque testing on the functional measures. The leg
used for functional assessment or control was alternated
between subjects to account for variability due to dominant
and non-dominant legs. At least 10 days prior to start of the
study, volunteers were subjected to pre-exercise (PRE) blood
collection. Blood samples were then withdrawn from each
individual volunteer at 6 h, 2 days, 5 days and 16 days post-
exercise. In addition, prior to exercise volunteers completed
two familiarization sessions in which they were acquainted
with the measurements and the procedures of the testing
and the exercise protocols wsee details in ‘Testing of muscle
function’ and ‘Maximal eccentric exercise protocol’ belowx.
The functional testing protocol consisted of the assessment
of maximal voluntary contractile (MVC) isometric torque of
the knee extensors, performed before (PRE) and on days 1,
2, 5, 8, 12, and 16 post-eccentric exercise. The time points of
blood sampling and functional measurements were chosen
to cover a wide period in the regeneration and adaptation
processes following muscle damage. In addition, delayed-
onset muscle soreness (DOMS) and changes in thigh circum-
ference were also measured. All measures were performed
on both legs at each time point of the testing protocol,
except for the maximal isometric torque which was per-
formed on the FL and CL before the eccentric exercise and
on day 16 post-exercise.
Testing of muscle function
Volunteers were familiarized with the torque testing proce-
dures on an isokinetic dynamometer (Cybex Norm Lumex,
Inc., Ronkonkoma, NY, USA) during two visits to the labo-
ratory. During each familiarization session, subjects warmed
up for 10 min on a cycle ergometer at 50 W. After this, they
performed a number of comfortable submaximal trials of
knee extension to become familiar with the procedures of
the isometric torque measurements and to learn proper exe-
cution of the exercise. During the second familiarization,
baseline measurements of the testing protocol (PRE) were
performed with the knee extensors of each leg, and baseline
measures were reassessed post-exercise as described
above. Maximal isometric torque was measured to evaluate
muscle function. Subjects were seated upright on the iso-
kinetic dynamometer with the knee joint aligned with the
axis of rotation of the dynamometer’s lever arm.
Maximal isometric torque
MVC isometric torque of the knee extensors was measured
at eight different knee angles, i.e., 15, 30, 45, 60, 75, 90, 105
and 1208, in random order across subjects and across days
for each subject. The knee angles used for MVC torque test-
ing were set using the dynamometer’s visual display unit
after entering a reference knee angle of 08, which was
defined as full knee extension. Each subject performed two
maximal voluntary isometric contractions of 3 s duration at
each angle. The best trial was used for the MVC isometric
torque of the angle.
Peak torque and optimum angle for peak torque genera-
tion were assessed using the isometric angle-torque curve.
The curve was determined for each subject by fitting a quad-
ratic polynomial curve to the torque vs. knee angle, as
described previously (21).
Maximal eccentric exercise protocol
Subjects performed an eccentric exercise routine with the
knee extensors of each leg on the isokinetic dynamometer
switched to the isokinetic mode. The exercise protocol con-
sisted of two sets of 25 maximal voluntary eccentric (length-
ening) muscle actions with a 5-min break between the sets.
Subjects were required to maximally resist the forced length-
ening of their quadriceps through a range of motion of 1308.
This range of motion represented almost full extension (58)
to almost full flexion. Subjects rotated internally the foot to
ensure sufficient activation of the vastus lateralis during
each muscle action. Each lengthening muscle action was
performed at an angular velocity of 308 s–1, lasted for ;4 s
and followed by a 15-s rest phase during which the leg was
returned passively to the starting position (58) by the dyna-
mometer motor. The eccentric exercise protocol lasted for a
total of ;22 min for each leg. The order of leg being exer-
cised was randomized across subjects. Subjects were
instructed to contract as forcefully as possible; strong verbal
encouragement was given during all trials.
Muscle torque, power and work during eccentric
exercise protocol
To evaluate total mechanical activity of the exercised mus-
cles during the eccentric exercise protocol, peak torque,
average power and total work were recorded throughout the
exercise routine for each leg.
Thigh circumference assessment
Changes in thigh circumference were used to estimate the
amount of intramuscular and subcutaneous swelling post-
exercise as an indicator of muscle damage (6, 22). Thigh cir-
cumference assessment of each leg was performed at the
start of each measurement session and preceded biopsy
and/or muscle function measurements. Circumference
measurements were taken by the same investigator using a
plastic tape measure at the point corresponding to one-third
between the spina iliaca anterior superior and the superior
pole of the patella. Subjects stood with their thigh muscles
relaxed during the measurement period. The accuracy of this
measurement is reported to be within 2 mm (22). The points
were marked on the subject’s skin with semi-permanent ink
to ensure consistent placement of the tape measure. Two
measurements were made and the average value recorded.
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Figure 1 Changes in thigh circumference compared to
pre-exercise (PRE) values (mean"SEM; ns10).
Thigh circumference was increased post-exercise indicating
damage-induced intramuscular and subcutaneous swelling
in the thigh. FL, functional leg; CL, control leg. Significantly
different from pre-exercise: *p-0.05; **p-0.01;
***p-0.001.
Muscle soreness
DOMS was evaluated for both legs before any contractions
were performed in each measurement session. The subjects
visually recorded the perceived pain on a visual analogue
scale that had a continuous line of 100 mm, with the left end
labeled ‘‘no pain’’ and the right end labeled ‘‘extremely
sore’’. Instructions were given to the subjects to rate sore-
ness levels in two ways: (i) during one repetition of flexing
and extending the knee joint throughout the entire range of
motion and (ii) upon light palpation of the entire knee exten-
sors area (i.e., the muscle belly and distal regions of the
quadriceps muscle). Palpation was always performed by the
same investigator, with the subjects thigh at rest (22). Sub-
jects marked the scale and the distance from the left end of
the scale to the mark was used as the level of soreness. The
average of the two values for each subject was used as the
criterion score for that day. DOMS was assessed each day
of function testing until subjects reported total disappear-
ance of pain.
Blood sampling and serum measurements
Blood samples were collected prior to (PRE) and after eccen-
tric exercise at 6 h, 2 days, 5 days and 16 days. The subjects
were at rest for at least 30 min prior to collection of 10 mL
of blood obtained from an antecubital vein. Blood samples
were allowed to clot at room temperature for 30 min. Serum
was collected following centrifugation at 2000 g at 48C for
10 min, stored frozen in 0.5 mL aliquots at –808C and thawed
one time only at the time of analysis. Measurement of serum
lactate dehydrogenase (LDH) activity was performed using
an automated commercially available kit (Roche Diagnostics,
Mannheim, Germany) in a Roche/Hitachi ACN 057 (Roche,
Mannheim, Germany) at 378C. Myoglobin concentrations in
serum were determined using an immunoturbidimetric
assay (Turbiquant, Dade Behring, Marburg, Germany).
Serum LDH activity and myoglobinemia were used as indi-
rect markers of muscle damage (10, 22). IL-6, OPG and
RANKL were determined by standard sandwich enzyme-
linked immunosorbent assay (ELISA) using commercially
available kits (IL-6: Quantikine HS, R&D Systems Inc., Min-
neapolis, USA; OPG and RANKL: Biomedica, Vienna, Austria)
according to the manufacturer’s instructions. Color forma-
tion was measured with a microplate reader (Versamax,
Molecular Devices, Sunnyvale, CA, USA) at 450 nm, and cal-
culations were performed using SoftMax Pro software
(Molecular Devices, Sunnyvale, CA, USA). Briefly, 96-well
microtiter plates (Costar) were coated with a monoclonal
antibody directed against the analyte. Samples and stan-
dards were applied and the bound analyte was detected with
horseradish peroxidase conjugated to a secondary polyclo-
nal antibody directed against the analyte. Visualization of the
presence of the peroxidase label was achieved with a tetra-
methylbenzidine (TMB) substrate. Color formation was
measured with a microplate reader (Versamax, Molecular
Devices, Sunnyvale, CA, USA) at 450 nm, and calculations
were performed using a SoftMax Pro software (Molecular
Devices, Sunnyvale, CA, USA). All samples were analyzed
simultaneously, in duplicate, and the results averaged.
According to manufacturers, the minimal detection limits of
the assays were 0.039 pg mL–1, 0.14 pmol mL–1, 0.08 pmol
mL–1 for IL-6, OPG and RANKL, respectively. The intra- and
inter-assay coefficients of variation (CV) were as follows:
6.9%–7.8% and 6.5%–9.6% for IL-6, 4%–10% and 7%–8% for
OPG, and 3%–5% and 6%–9% for RANKL.
Statistical analysis
Changes in measures of function were assessed using a two-
way analysis of variance (ANOVA) with repeated measures
(SPPS v. 11 statistical package; SPSS Inc., Chicago, IL, USA).
A one-way ANOVA with repeated measures over time was
employed to evaluate changes in all serum measurements.
Significant F ratios for main effects or interaction (p-0.05)
were evaluated by comparing the mean values using Tukey’s
post-hoc tests. Relationships between variables were exam-
ined using Pearson’s correlation coefficient (r). All data are
presented as mean"standard error of the mean (SEM). Sta-
tistically significant changes were considered at p-0.05.
Results
Assessment of eccentric exercise-induced muscle
damage
All volunteers reported significant muscle soreness in
both legs (p-0.01), which peaked on day 2 post-exer-
cise w42.5 mm (5.1) for the FL and 50 mm (6.7) for the
CLx. No significant differences were found between
legs (p)0.05).
Thigh circumference was significantly increased
post-exercise, with the highest scores occurring on
days 2 and 5 post-exercise for both legs. Scores
remained elevated up to day 16 on the FL, and grad-
ually decreased from days 8–16 on CL (Figure 1). No
significant differences were found in thigh circumfer-
ence between legs post-exercise (p)0.05).
Classical biochemical markers of muscle damage
were elevated post maximal eccentric exercise pro-
tocol. LDH activity was increased and remained ele-
vated up to day 5 post-exercise, while myoglobin
concentrations were significantly increased at 6 h and
on day 2 post-exercise (Figure 2).
Assessment of muscle function following eccentric
exercise-induced damage
As expected, a significant (p-0.001) gradual decrease
in peak torque wby 37.5% (5.9) for FL and by 33.4%
780 Philippou et al.: Cytokine response to exercise-induced muscle damage
Article in press - uncorrected proof
Figure 2 Serum lactate dehydrogenase (LDH) activity (A)
and myoglobin concentrations (B) before (PRE) and after
maximal eccentric exercise of both legs (mean"SEM;
ns10).
LDH activity was increased and remained elevated up to day
5 post-exercise. Myoglobin concentrations were increased at
6 h and day 2 post-exercise. *Significantly different from
pre-exercise (p-0.05).
Figure 3 Percent changes in peak isometric torque of knee
extensors, calculated using the curve fitting procedure, com-
pared to pre-exercise (mean"SEM; ns10).
Peak torque decreased over time compared to pre-exercise
levels. FL, functional leg; CL, control leg. Significantly differ-
ent from pre-exercise: **p-0.01; ***p-0.001.
(5.7) for CLx, average power wby 41.3% (5.0) for FL and
by 43.1% (3.0) for CLx and total work wby 42.2% (4.8)
for FL and by 41.3% (3.6) for CLx was shown at the
end of the course of the eccentric exercise protocol.
There were no differences between the two legs in
any of the above measures (p)0.05). Similar esti-
mates of the above parameters of muscle function
indicate that both the functional assessment (FL) and
the control leg (CL) underwent the same effects by the
exercise protocol.
Peak isometric torque (Figure 3) was significantly
changed over time compared with pre-exercise levels.
Further, there was not any training effect of the
repeated maximal torque testing on the functional
responses of the FL and CL by day 16 post-exercise
(i.e., no differences in percent changes of peak torque
were found between legs by day 16 post-exercise;
Figure 3).
Assessment of cytokine response in blood following
eccentric exercise-induced damage
The coefficient r2 for standard curves of all the ELISA
analyses was G0.98. Analysis of inflammation-related
factors in the blood revealed a significant increase in
serum IL-6 and OPG, and a decrease in RANKL. In
addition, the OPG:RANKL ratio was found to be sig-
nificantly increased post-exercise (Figure 4). Correla-
tional analyses revealed some noteworthy associa-
tions; peak IL-6 was positively related to the peak OPG
(rs0.64, p-0.05) as well as to the peak OPG:RANKL
ratio (rs0.90, p-0.05).
Discussion
The eccentric exercise protocol used in this study
resulted in skeletal muscle damage, as indicated by
the sustained changes in the clinical markers of dam-
age. Parameters affected included muscle soreness
and swelling, a deficit in muscle torque generation
and the leakage of muscle proteins into the blood
post-exercise.
The molecular mechanisms involved in the muscle
repair process following damage include an inflam-
matory response within the damaged muscle (13, 23).
Damage-induced cytokine responses have been dem-
onstrated by increased concentrations of IL-1, IL-6 and
IL-10 following high-intensity eccentric exercise (10,
16). Among these, IL-6 is an inflammation-responsive
cytokine. Although it has been classified as both a
pro- and anti-inflammatory cytokine, the current view
is that it acts primarily as an anti-inflammatory factor
(18, 24). Our data on inflammation-dependent bio-
markers seem to support the concept of a balance
between pro-inflammatory and anti-inflammatory fac-
tors, which coordinate inflammation and regeneration
processes during muscle regeneration (13). An acute
inflammatory response appeared to accompany the
adaptation process following damage in the present
study. This was indicated by the increase in serum IL-
6 concentrations within hours post-exercise, corrob-
orating previously published data (10, 16). The early
increase in serum IL-6 post eccentric exercise-induced
muscle damage has been assumed to originate from
inflammatory cells infiltrating damaged skeletal mus-
cle (9, 24). The interactions between muscle and the
infiltrating inflammatory cells appear to affect the out-
come of the repair process. Cytokines released at the
site of damage by activated inflammatory cells and
muscle cells act as modulators of the inflammatory
process (13). Among those cytokines, it has been sug-
gested that IL-6 controls an excessive inflammatory
response following muscle damage, and negatively
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Figure 4 Serum concentrations of (A) IL-6, (B) OPG, and
(C) RANKL, and (D) OPG:RANKL ratio before (PRE) and after
maximal eccentric exercise of both legs (mean"SEM;
ns10).
OPG and IL-6 concentrations were increased and RANKL was
decreased at 6 h and day 2 post-exercise. The OPG:RANKL
ratio was increased at 6 h post-exercise. *Significantly dif-
ferent from pre-exercise (p-0.05).
regulates the acute phase inflammatory response
(24). Muscle contractions per se are a stimulus for the
production of muscle-derived IL-6 (24–26). However,
the kinetics of IL-6 production have shown a progres-
sive increase following muscle-damaging eccentric
exercise (10, 16). This is in contrast to the rapid
decline of IL-6 concentrations following non-damag-
ing concentric exercise of long duration (24, 26, 27).
In agreement with previous findings (16), we found a
prolonged increase in IL-6 which could reflect a key
role of IL-6 in the repair mechanism after muscle dam-
age (10, 24).
Given that the immune system is modulated by
exercise (18), it has been previously proposed that
inflammation-related changes following exercise-
induced muscle damage could be manifestations of
adaptive responses involving immunological events
(28). The OPG/RANKL system appears to constitute a
complex mediator system involved in the regulation
of immune cell function (19). The RANK/RANKL sys-
tem appears to play a major role in the regulation and
function of the immune response (20). Conversely,
the RANK/RANKL system is blocked by OPG and anti-
inflammatory cytokines such as IL-4 and IL-10, which
inhibit inflammation (29). Thus, it is speculated that
the increases in both OPG and OPG:RANKL ratio
found in the present study could be an anti-inflam-
matory response to acute phase inflammation that
takes place following damage. Similar findings have
been reported following myocardial infarction in
human subjects (30).
Our results showing increases in IL-6 and OPG and
their similar kinetics, combined with the simultaneous
decrease in serum RANKL concentrations suggest
that these could reflect an anti-inflammatory systemic
reaction to muscle damage. Interestingly, previous
findings have shown that both IL-6 and OPG inhibit
TNF-a – and IL-1 – mediated inflammation (24, 29).
Furthermore, our findings appear to be in agreement
with suggestions that IL-6 is a key cytokine in the
acute phase response, having an inflammation-con-
trolling role and regulating homeostasis following an
inflammatory reaction (18, 24, 31, 32). The correlation
between increasing concentrations of IL-6 and OPG,
as well as the OPG:RANKL ratio post-exercise, could
indicate a common modulating role of IL-6 and the
OPG/RANKL system during skeletal muscle regener-
ation following damage. To our knowledge, this is the
first report regarding changes in the OPG/RANKL sys-
tem following exercise-induced muscle damage in
humans. Further studies are required to elucidate the
potential systemic modulating function of this system
following muscle damage. However, it cannot be
excluded that the systemic changes in the OPG/
RANKL system observed in the present study are not
closely associated with the changes occurring within
the muscle after damage. Thus, their potential signif-
icance regarding muscle inflammation and/or repair
process remains to be determined.
In conclusion, we provide the first evidence of the
OPG/RANKL system response along with that of IL-6
and other biochemical markers following exercise-
induced muscle damage in humans. Clearly, more
studies are needed in order to elucidate any systemic
and/or local role of the OPG/RANKL system in skeletal
muscle inflammation and repair.
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